Vital Stone Financial, LLC Dexcom Inc Transaction History

Vital Stone Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$110.31 - $140.45 $992 - $1,264	9 Added 40.91%	31 $3,000
Q1 2024 May 06, 2024	SELL	$114.22 - $140.1 $7,424 - $9,106	-65 Reduced 74.71%	22 $3,000
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $1,887 - $3,104	-25 Reduced 22.32%	87 $11,000
Q3 2023 Nov 15, 2023	BUY	$86.06 - $137.93 $8,606 - $13,793	100 Added 833.33%	112 $11,000
Q2 2023 Aug 21, 2023	SELL	$112.47 - $130.98 $112 - $130	-1 Reduced 7.69%	12 $1,000
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $104 - $122	1 Added 8.33%	13 $7,000
Q4 2022 Jan 30, 2023	BUY	$84.98 - $122.67 $1,019 - $1,472	12 New	12 $1 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Vital Stone Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Vital Stone Financial, LLC with notifications on news.